Biotech Holdings LtdShs News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Trading-Depot	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Trading-Depot

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

31.08.25	UK biotech to trial cancer treatment based on ‘super donor’ immune cells (Financial Times)
11.08.25	Return of FDA official targeted by Trump allies hits biotech shares (Financial Times)
14.07.25	Chinese biotech shares surge as Big Pharma looks to license cancer treatments (Financial Times)
06.07.25	Boston’s biotech sector reels due to Trump health policy uncertainty (Financial Times)
18.06.25	Welsh biotech wins funding to develop new depression treatments (Financial Times)
18.06.25	FDA chief seeks to soothe US biotech fears over drug approval timeline (Financial Times)
17.06.25	Eli Lilly strikes deal to buy Crispr gene-editing biotech Verve (Financial Times)
13.06.25	AstraZeneca signs $5.2bn deal to develop drugs for chronic disease with Chinese biotech (Financial Times)
08.06.25	Biotech behind Eli Lilly obesity pill aims for new standard of care (Financial Times)
02.06.25	Merck held talks to buy Swiss biotech MoonLake for more than $3bn (Financial Times)
02.06.25	Biotech M&A shows signs of life (Financial Times)
10.05.25	Biotech billionaire Christian Angermayer: ‘Psychedelics can take away the fear’ (Financial Times)
28.04.25	Germany’s Merck to buy US biotech SpringWorks for $3.9bn (Financial Times)
02.04.25	A biotech M&A revival is in the pipeline (Financial Times)
17.03.25	AstraZeneca buys cell therapy biotech in up to $1bn deal (Financial Times)
16.02.25	Biotech behind Alzheimer’s drug seeks partners for blood-brain barrier technology (Financial Times)
11.02.25	Novartis agrees $3bn deal to buy heart drug biotech from Blackstone (Financial Times)
13.01.25	J&J strikes $14.6bn deal for neuroscience biotech Intra-Cellular (Financial Times)
10.01.25	Eli Lilly in advanced talks to buy US cancer biotech for up to $2.5bn (Financial Times)
10.01.25	Musk ally leads attempt to seize control of psychedelic biotech Lykos (Financial Times)
09.01.25	General Atlantic-backed biotech start-up secures $410mn in initial funding round (Financial Times)
08.01.25	GSK nears $1bn deal for biotech developing drug for rare tumour (Financial Times)
24.12.24	UK biotech takes on personalised cancer therapy side effects (Financial Times)
23.12.24	Why bigger is not always better in biotech (Financial Times)
21.11.24	US biotech 23andMe hits new lows as Sequoia Capital sells down stake (Financial Times)
16.11.24	A small biotech fund gets a boost from Wall Street titans (Financial Times)
15.11.24	Biotech: US-Konkurrent bietet zwei Milliarden Euro für Evotec - Aktie steigt um 20 Prozent (Handelsblatt)
11.11.24	Biotech: Triton erwägt offenbar Übernahme von Evotec - Aktie steigt zweistellig (Handelsblatt)
03.10.24	Technologie: Immer mehr grosse Finanzierungerunden: Frisches Geld für Biotech made in Germany (Handelsblatt)
10.06.20	Singapore biotech firm Tychan to start human trials for COVID-19 treatment next week (Reuters)
26.05.20	Ex-biotech CEO pleads guilty in U.S. college admissions scandal (Reuters)
14.05.20	U.S.-Israeli biotech startup Immunai raises $20 million (Reuters)
25.04.20	German biotech firm working on COVID-19 vaccines rejects takeover approaches (Reuters)
17.03.20	German biotech CureVac says it has had no U.S. takeover offer (Reuters)
09.12.19	France's Sanofi to buy biotech firm Synthorx for $2.5 billion (Reuters)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Roche Hldg G	259.90	1.48 %	K V
Lonza Grp	527.20	1.42 %	K V
Nestle	73.07	1.36 %	K V
Geberit	597.20	1.36 %	K V
Sika	177.10	0.03 %	K V
UBS Group	32.51	-0.06 %	K V
Swisscom	577.50	-0.09 %	K V
Part Grp Hldg	1’033.50	-0.29 %	K V
Kuehne+Nagel Int	148.15	-2.24 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Biotech Holdings LtdShs Aktie ISIN CA0909381018

Nachrichten zu Biotech Holdings LtdShs

Aktien Top/Flop

Meistgelesene Nachrichten